Search results for: Category

Dallas site enrolls for global IDE study evaluating use of coronary IVL in the U.S.

Baylor Scott & White Heart & Vascular Hospital Dallas is currently enrolling patients for a prospective, multicenter, single-arm, global investigational device exemption (IDE) study to evaluate the safety and effectiveness of the Shockwave Coronary IVL System in de novo, calcified, stenotic coronary arteries prior to stenting. Disrupt CAD III is being conducted as a staged pivotal study.

Read more

Study findings address response to structured aerobic exercise in patients with baseline chronic liver disease and long-term heart failure with reduced ejection fraction

Researchers recently published findings based on secondary analysis of a study, HF-ACTION, examining the impact of structured aerobic exercise on patients with long-term heart failure with reduced ejection fraction (HFrEF). The secondary analysis applied the association of baseline chronic liver disease (CLD) on the benefits of structured aerobic exercise for the patients.

Read more